鼻窦癌同步整合预防性全脑照射
本文报告两例鼻窦侵袭性肿瘤患者接受放疗时同步整合预防性全脑照射,采用两个序贯计划,化疗贯穿放疗前后及期间。两例均未出现颅内复发,一例出现严重但短暂的类脑炎症状且仅归因于放疗,未观察到中枢神经系统长期副作用。该治疗可行但可能有严重短暂副作用,应考虑用于颅内转移高风险且原发照射体积与脑显著重叠的头颈癌病例。
要点
- 鼻窦小细胞癌与高级别神经内分泌肿瘤治疗常外推自小细胞肺癌及不同组织学鼻窦癌。
- 两例采用同步整合预防性全脑照射,化疗贯穿放疗前、中、后,均无颅内复发。
- 一例出现严重但短暂的类脑炎症状,仅归因于放疗,无中枢神经系统长期副作用。
核心结论
- 鼻窦癌同步整合预防性全脑照射可行,但可能伴有严重而短暂的副作用。
- 该策略可考虑用于颅内转移高风险且原发照射体积与脑显著重叠的头颈癌病例。
研究设计与样本
- 两例鼻窦侵袭性肿瘤患者接受放疗并同步整合预防性全脑照射,采用两个序贯计划。
- 化疗在放疗前、放疗期间及放疗后给予。
主要发现
- 两例患者均未出现颅内复发。
- 一例患者出现严重但短暂的类脑炎症状,且仅可归因于放疗。
- 未观察到中枢神经系统长期副作用。
临床怎么用
- 对鼻窦小细胞癌或高级别神经内分泌肿瘤等颅内转移高风险且原发照射体积与脑显著重叠的头颈癌,可考虑同步整合预防性全脑照射。
- 治疗中需警惕严重但短暂的类脑炎症状,并监测中枢神经系统长期副作用。
局限性
- 仅基于两例患者的经验,证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Therapy for small cell cancer and high grade neuroendocrine tumours of the paranasal sinuses is extrapolated from the treatment of small cell lung cancer and paranasal cancer of different histologies. Prophylactic cranial irradiation has proven survival benefit in small cell lung cancer. Two patients with aggressive cancer of the paranasal sinuses received radiotherapy with simultaneous integrated prophylactic brain irradiation, using two sequential plans. Chemotherapy was given before, during and after radiotherapy. None of the patients had intracranial recurrence. One patient experienced severe, but transient encephalitis-like symptoms that could only be attributed to radiotherapy. No long term side effects in the CNS were observed. The treatment was feasible, but with possible severe, but transient side effects. It should be considered in cases with head and neck cancer, with a high risk of intracerebral metastasis, as well as a significant overlap between the primary irradiated volume and the brain.
引用
- Jensen K, Sharma MB, Lenler-Eriksen S, et al. Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer. Clin Transl Radiat Oncol. 2017. PMID: 29658002. doi:10.1016/j.ctro.2017.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。